Santoro A, Basile C
Unità Operativa Complessa di Nefrologia e Dialisi, Policlinico S. Orsola-Malpighi, Bologna.
G Ital Nefrol. 2006 Nov-Dec;23(6):552-9.
Despite substantial progress in dialysis technology, cardiovascular disease remain the sole major cause of death in chronic dialysis patients. Nearly half of deaths on chronic maintenance hemodialysis are secondary to myocardial infarction, cardiac arrest, malignant arrhythmias and other cardiac causes. In fact, diabetes, anemia, hyperparathyroidism, and hypertension wide prevalence among chronic dialysis patients foster structural heart diseases. Moreover fluid overload and metabolic abnormalities such as metabolic acidosis, dyskalemia, dysmagnesemia lead to an increased risk of clinically significant ventricular arrhythmias and sudden cardiac death. During dialysis patients show a non-homogeneous repolarization through an increase in Q-T duration and Q-T dispersion. The dialysis-related sudden variation in extra-cellular potassium, calcium and pH levels may be contributing factors to the genesis of an electrical disequilibrium in myocardial cells. One of the potential therapeutic options is, in fact, adjusting the dialysis bath. The K profiling with non-constant K concentration in the dialysate, but with high concentration in the first hour of dialysis and progressive reduction until the end of the session, seems very promising in reducing the arrhythmic risk in cardiomyopathy patients.
尽管透析技术取得了重大进展,但心血管疾病仍然是慢性透析患者唯一的主要死因。慢性维持性血液透析患者中近一半的死亡继发于心肌梗死、心脏骤停、恶性心律失常和其他心脏原因。事实上,糖尿病、贫血、甲状旁腺功能亢进和高血压在慢性透析患者中广泛存在,会引发结构性心脏病。此外,液体超负荷以及代谢异常,如代谢性酸中毒、血钾异常、血镁异常,会增加临床上显著室性心律失常和心源性猝死的风险。在透析过程中,患者会通过QT间期延长和QT离散度增加表现出复极不均一性。透析相关的细胞外钾、钙和pH值水平的突然变化可能是心肌细胞电失衡发生的促成因素。事实上,一种潜在的治疗选择是调整透析液。采用透析液中钾浓度不恒定的钾谱模式,即在透析开始的第一个小时采用高浓度,然后逐渐降低直至透析结束,这在降低心肌病患者的心律失常风险方面似乎非常有前景。